Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Elekta AB ( ($SE:EKTA.B) ) is now available.
Elekta has appointed its Nomination Committee for the 2026 Annual General Meeting, consisting of representatives from major stakeholders including the Fourth Swedish National Pension Fund, Nordea Funds, SEB Funds, and Lannebo Kapitalförvaltning. This strategic move ensures diverse representation and stakeholder engagement in the company’s governance, potentially impacting its strategic direction and reinforcing its commitment to collaborative leadership.
The most recent analyst rating on ($SE:EKTA.B) stock is a Hold with a SEK50.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta is a leader in precision radiation therapy, dedicated to providing the best cancer care through innovative, sustainable, and cost-efficient solutions. Headquartered in Stockholm, Sweden, with a global presence in over 40 countries, Elekta is committed to advancing cancer treatment and improving patient outcomes.
Average Trading Volume: 1,093,600
Technical Sentiment Signal: Strong Sell
Current Market Cap: SEK18.6B
For an in-depth examination of EKTA.B stock, go to TipRanks’ Overview page.